NAGE FY 2013 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$391M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-12.5% YoY

Gross Profit

$3M30.8% margin

Operating Income

-$4M-43.2% margin

Net Income

-$4M-43.5% margin

EPS (Diluted)

$-0.13

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$9M

Total Liabilities

$3M

Stockholders' Equity

$6M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$12M	-12.5%
Gross Profit	$3M	$2M	+37.7%
Operating Income	-$4M	-$12M	+62.3%
Net Income	-$4M	-$12M	+62.1%